Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IIITerminatedJan 20, 2021Oxycodone Hydrochloride Oral SolutionPresence of Foreign Substance: Particulate matter was found in multiple lots of product.Genus Lifesciences Inc. · D-0231-2021Class IIOngoingJan 20, 2021Zapien Productos Hand Sanitizer Gel AntibacterialcGMP deviations: Product made at the same facility where product tested was sub-potent.Gaza Proveedora De Servicios De Hospedaje Y Alimentacion · D-0230-2021Class IIOngoingJan 20, 2021Pristine gel Hand Sanitizer Gel Antibacterial Gel MoisturizingcGMP deviations: Product made at the same facility where product tested was sub-potent.Gaza Proveedora De Servicios De Hospedaje Y Alimentacion · D-0229-2021Class IITerminatedJan 20, 2021Chlorhexidine Gluconate Oral Rinse USP 0.12%cGMP deviations: The firm was notified of the manufacturer's expanded recall.Precision Dose Inc. · D-0228-2021Class IIOngoingJan 20, 2021Metformin Hydrochloride Extended-Release TabletsCGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake levelNostrum Laboratories Inc · D-0227-2021Class IITerminatedJan 20, 2021MethotrexateLack of Assurance of Sterility; the media used to conduct post-compounding sterility testing for the Methotrexate product was expired.Edge Pharma, LLC · D-0226-2021Class IIITerminatedJan 20, 2021Benzhydrocodone and Acetaminophen TabletsFailed Impurities/Degradation Specifications; out of specification results obtained for N-Oxide impurity during the 12-month long term stability testing for Batch# 15892AKVK-Tech, Inc. · D-0224-2021Class IIITerminatedJan 20, 2021Succinylcholine Chloride PF Inj. 200 mg/10 mLLabeling: Incorrect or Missing lot and/or expiration date: The lot number and BUD were printed in the incorrect position on the product label making it illegible.US Compounding Inc · D-0223-2021Class IIOngoingJan 20, 2021Paroex (Chlorhexidine Gluconate) Oral RinsecGMP Deviations; FDA inspection of manufacturing facility observed potential Burkholderia cepacia complex (BCC) contamination, inadequate cleaning, inadequate...Sunstar Americas, Inc. · D-0222-2021Class IITerminatedJan 20, 2021Levetiracetam Oral SolutionDefective container: Customer complaints for oral solution leaking from bottles.Akorn, Inc. · D-0221-2021Class IITerminatedJan 13, 2021Ketamine 50 mg/5mL in 0.9% Sodium Chloride InjectionLack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unitSCA Pharmaceuticals · D-0217-2021Class IITerminatedJan 13, 2021PHENYLephrine HCl 5000 mg/50 mL in Sodium Chloride 0.9%Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unitSCA Pharmaceuticals · D-0216-2021Class IITerminatedJan 13, 2021HYDROmorphone HCl 10mg/50mL in 0.9% Sodium Chloride InjectionLack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unitSCA Pharmaceuticals · D-0215-2021Class IITerminatedJan 13, 2021fentaNYL 100 mcg/2mL Injection for IV or IM UseLack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unitSCA Pharmaceuticals · D-0214-2021Class IITerminatedJan 13, 2021ePHEDrine 25 mg/5 mL in 0.9% Sodium Chloride InjectionLack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unitSCA Pharmaceuticals · D-0213-2021Class IITerminatedJan 13, 2021SUCcinylcholine Chloride 100 mg/5mLLack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unitSCA Pharmaceuticals · D-0212-2021Class IITerminatedJan 13, 2021Rocuronium Br 50 mg/5mLLack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unitSCA Pharmaceuticals · D-0211-2021Class IITerminatedJan 13, 2021PHENYLephrine HCl 500 mcg/5mL in 0.9% Sodium ChlorideLack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unitSCA Pharmaceuticals · D-0210-2021Class IITerminatedJan 13, 2021Morphine Sulfate 30 mg/30 mL in 0.9% Sodium ChlorideLack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unitSCA Pharmaceuticals · D-0209-2021Class IITerminatedJan 13, 2021SUCccinylcholine Chloride 200 mg/10 mLLack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unitSCA Pharmaceuticals · D-0208-2021Class IITerminatedJan 13, 2021Sodium Citrate 4% 3 mL Anticoagulation SolutionLack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unitSCA Pharmaceuticals · D-0207-2021Class IITerminatedJan 13, 2021Rocuronium Br 100 mg/10mLLack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unitSCA Pharmaceuticals · D-0206-2021Class IITerminatedJan 13, 2021PHENYLephrine HCl 800 mcg/10 mL in 0.9% Sodium ChlorideLack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unitSCA Pharmaceuticals · D-0205-2021Class IITerminatedJan 13, 2021PHENYLephrine HCl 1000 mcg/10 mL in 0.9% Sodium ChlorideLack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unitSCA Pharmaceuticals · D-0204-2021Class IITerminatedJan 13, 2021neostigmine methylsulfate 5 mg/5 mLLack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unitSCA Pharmaceuticals · D-0203-2021Class IITerminatedJan 13, 2021morphine sulfate 150 mg/30 mL in 0.9% Sodium Chloride InjectionLack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unitSCA Pharmaceuticals · D-0202-2021Class IIITerminatedJan 13, 2021Morphine Sulfate 3 mg/3 mL in 0.9% Sodium ChlorideLack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unitSCA Pharmaceuticals · D-0201-2021Class IITerminatedJan 13, 2021Lidocaine HCl 2% 5 mLLack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unitSCA Pharmaceuticals · D-0200-2021Class IITerminatedJan 13, 2021Lidocaine HCl 1% 10 mLLack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unitSCA Pharmaceuticals · D-0199-2021Class IITerminatedJan 13, 2021labetalol HCl 20 mg/4 mLLack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unitSCA Pharmaceuticals · D-0198-2021Class IITerminatedJan 13, 2021Ketamine 100 mg/10mL in 0.9% Sodium Chloride InjectionLack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unitSCA Pharmaceuticals · D-0197-2021Class IITerminatedJan 13, 2021HYDROmorphone HCl 30 mg/30 mL in 0.9% Sodium Chloride InjectionLack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unitSCA Pharmaceuticals · D-0196-2021Class IITerminatedJan 13, 2021HYDROmorphone HCl 6 mg/30mL in 0.9% Sodium Chloride InjectionLack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unitSCA Pharmaceuticals · D-0195-2021Class IITerminatedJan 13, 2021Glycopyrrolate 1 mg/5mLLack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unitSCA Pharmaceuticals · D-0194-2021Class IITerminatedJan 13, 2021fentaNYL 1500 mcg/30 mLLack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unitSCA Pharmaceuticals · D-0193-2021Class IITerminatedJan 13, 2021fentaNYL 100 mcg/50mL Bupivacaine HCl 0.125% in 0.9% Sodium Chloride 50 mLLack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unitSCA Pharmaceuticals · D-0192-2021Class IITerminatedJan 13, 2021fentaNYL 100 mcg/50mL Ropivacaine HCl 0.1% in 0.9% Sodium Chloride 50 mLLack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unitSCA Pharmaceuticals · D-0191-2021Class IITerminatedJan 13, 2021Esmolol HCl 100 mg/10 mLLack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unitSCA Pharmaceuticals · D-0190-2021Class IITerminatedJan 13, 2021ePHEDrine Sulfate 50 mg/10mL in 0.9% Sodium Chloride InjectionLack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unitSCA Pharmaceuticals · D-0189-2021Class IITerminatedJan 13, 2021ePHEDrine SulfateLack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unitSCA Pharmaceuticals · D-0188-2021